Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SiOxD® Wound Matrix

K-Number: K241660 · 2024-07-05

ApplicantSioxmed, LLC
Decision Date2024-07-05
Product CodeQSZ
DecisionSubstantially Equivalent

Device Summary

SiOxD® Wound Matrix is a medical device manufactured by Sioxmed, LLC. It received FDA 510(k) clearance on 2024-07-05 under approval number K241660. The device is classified under product code QSZ. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SiOxD® Wound Matrix?

SiOxD® Wound Matrix is a medical device that received FDA 510(k) clearance on 2024-07-05. It is manufactured by Sioxmed, LLC. The 510(k) number is K241660.

When was SiOxD® Wound Matrix approved by the FDA?

SiOxD® Wound Matrix received FDA 510(k) clearance on 2024-07-05, under approval number K241660.

What company makes SiOxD® Wound Matrix?

SiOxD® Wound Matrix is manufactured by Sioxmed, LLC.

What is the FDA product code for SiOxD® Wound Matrix?

The FDA product code for SiOxD® Wound Matrix is QSZ.

Related Clinical Trials

Other Devices by Sioxmed, LLC

Related Devices (Code: QSZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.